Dexcom Inc. logo

Dexcom Inc. (DXCM)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
65. 49
+0.24
+0.37%
$
24.46B Market Cap
134.71 P/E Ratio
0% Div Yield
3,644,150 Volume
1.43 Eps
$ 65.25
Previous Close
Day Range
65.15 66.75
Year Range
54.11 93.25
Want to track DXCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – DXCM

DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – DXCM

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM

October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DexCom (DXCM) Blamed Disruptive Sales Force Changes For Its Disappointing Q2 2024 Results And Outlook, Resulting In 40% Stock Drop And Class Action - Hagens Berman

DexCom (DXCM) Blamed Disruptive Sales Force Changes For Its Disappointing Q2 2024 Results And Outlook, Resulting In 40% Stock Drop And Class Action - Hagens Berman

SAN FRANCISCO, CA / ACCESSWIRE / September 25, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Accesswire | 1 year ago
DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - DXCM

DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - DXCM

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Shareholders That Lost Money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Shareholders That Lost Money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Shareholders Are Invited To Join The Schall Law Firm In A Case Against DexCom, Inc. For Violating Securities Laws

Shareholders Are Invited To Join The Schall Law Firm In A Case Against DexCom, Inc. For Violating Securities Laws

LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 8, 2024 and July 25, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 21, 2024.

Accesswire | 1 year ago
DexCom Is Great. Here's Why You Shouldn't Buy It.

DexCom Is Great. Here's Why You Shouldn't Buy It.

DexCom seems to be growing fairly consistently, and that could continue. But the competition for its segment is getting fiercer by the quarter.

Fool | 1 year ago
Is DexCom a Millionaire Maker?

Is DexCom a Millionaire Maker?

DexCom could credibly grow at a decent clip for a long period. Its ongoing international expansion is its main growth driver for now.

Fool | 1 year ago
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DXCM Shareholders Have Opportunity to Lead DexCom, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

DXCM Shareholders Have Opportunity to Lead DexCom, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESSWIRE / September 25, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DexCom securities between January 8, 2024, and July 25, 2024, inclusive (the "Class Period").

Accesswire | 1 year ago
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – DXCM

DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – DXCM

NEW YORK, NY / ACCESSWIRE / September 24, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Loading...
Load More